The atypia of undetermined significance/follicular lesion of undetermined significance: Malignant ratio

Cancer Cytopathology

Volumn 120, Issue 2, 2012, Pages 111-116

  Krane, Jeffrey F ^a   VanderLaan, Paul A ^a   Faquin, William C ^b   Renshaw, Andrew A ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

Atypia; Atypia of undetermined significance follicular lesion of undetermined significance (AUS); Bethesda; Fine needle aspiration; Health care quality assurance; Thyroid gland; Thyroid nodule

Indexed keywords

ARTICLE; ATYPIA OF UNDETERMINED SIGNIFICANCE MALIGNANT RATIO; CYTOPATHOLOGY; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; FINE NEEDLE ASPIRATION BIOPSY; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOTAL QUALITY MANAGEMENT; ADENOCARCINOMA; NEEDLE BIOPSY; PATHOLOGY; REVIEW; THYROID GLAND; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; HUMANS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84861652635     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20192     Document Type: Article

References (16)

1. Ali SZ, Cibas ES, eds. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes. New York: Springer; 2010.
2. Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer (Cancer Cytopathol). 2010;118:415-422.
3. Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38:731-739.
4. Jing X, Roh MH, Knoepp SM, Zhao L, Michael CW. Minimizing the diagnosis of ''follicular lesion of undetermined significance'' and identifying predictive features for neoplasia [published online ahead of print October 14, 2010]. Diagn Cytopathol.
5. Jo VY, Stelow EB, Dustin SM, Hanley KZ. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010;134:450-456.
6. Kim SK, Hwang TS, Yoo YB, et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab. 2011;96:658-664.
7. Layfield LJ, Morton MJ, Cramer HM, Hirschowitz S. Implications of the proposed thyroid fine-needle aspiration category of ''follicular lesion of undetermined significance'': a five-year multi-institutional analysis. Diagn Cytopathol. 2009;37:710-714.
8. Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fineneedle aspiration biopsies. Diagn Cytopathol. 2010;38:252-259.
9. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer (Cancer Cytopathol). 2009;117:195-202.
10. Ohori NP, Nikiforova MN, Schoedel KE, et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of ''follicular lesion of undetermined significance/atypia of undetermined significance.'' Cancer (Cancer Cytopathol). 2010;118:17-23.
11. Rabaglia JL, Kabbani W, Wallace L, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery. 2010;148:1267-1272; discussion 1272-1273.
12. Renshaw AA. Should ''atypical follicular cells'' in thyroid fine-needle aspirates be subclassified? Cancer (Cancer Cytopathol). 2010;118:186-189.
13. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009;19:1215-1223.
14. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol. 2011;135:770-775.
15. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11:390-396.
16. Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy [published online ahead of print March 25, 2011]. Cancer (Cancer Cytopathol).